BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15667000)

  • 1. secErbB4-26/549 antagonizes ligand-induced ErbB4 tyrosine phosphorylation.
    Gilmore JL; Riese DJ
    Oncol Res; 2004; 14(11-12):589-602. PubMed ID: 15667000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand discrimination in signaling through an ErbB4 receptor homodimer.
    Sweeney C; Lai C; Riese DJ; Diamonti AJ; Cantley LC; Carraway KL
    J Biol Chem; 2000 Jun; 275(26):19803-7. PubMed ID: 10867024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
    Wilson KJ; Mill CP; Gallo RM; Cameron EM; VanBrocklin H; Settleman J; Riese DJ
    Biochem J; 2012 Apr; 443(1):133-44. PubMed ID: 22216880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent regulation of ErbB4 receptor phosphorylation by activated Ras.
    Tal-Or P; Erlich S; Porat-Shliom N; Goldshmit Y; Ben-Baruch G; Shaharabani E; Kloog Y; Pinkas-Kramarski R
    J Cell Biochem; 2006 Aug; 98(6):1482-94. PubMed ID: 16518842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056.
    Gallo RM; Riese DJ
    Growth Factors; 2007 Oct; 25(5):329-33. PubMed ID: 18236211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.
    Huang Z; Wang Y; Nayak PS; Dammann CE; Sanchez-Esteban J
    J Biol Chem; 2012 May; 287(22):18091-102. PubMed ID: 22493501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.
    Kaushansky A; Gordus A; Budnik BA; Lane WS; Rush J; MacBeath G
    Chem Biol; 2008 Aug; 15(8):808-17. PubMed ID: 18721752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-conversion of neuregulin2 full and partial agonists for ErbB4.
    Wilson KJ; Mill CP; Cameron EM; Hobbs SS; Hammer RP; Riese DJ
    Biochem Biophys Res Commun; 2007 Dec; 364(2):351-7. PubMed ID: 17945187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.
    Pitfield SE; Bryant I; Penington DJ; Park G; Riese DJ
    Oncol Res; 2006; 16(4):179-93. PubMed ID: 17120616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase.
    Hobbs SS; Cameron EM; Hammer RP; Le AT; Gallo RM; Blommel EN; Coffing SL; Chang H; Riese DJ
    Oncogene; 2004 Jan; 23(4):883-93. PubMed ID: 14661053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization by different strategies of epidermal growth factor receptor and ErbB4.
    Yamamoto H; Higa-Nakamine S; Noguchi N; Maeda N; Kondo Y; Toku S; Kukita I; Sugahara K
    J Pharmacol Sci; 2014; 124(3):287-93. PubMed ID: 24553453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
    Earp HS; Dawson TL; Li X; Yu H
    Breast Cancer Res Treat; 1995 Jul; 35(1):115-32. PubMed ID: 7612898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
    Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells.
    Yumoto N; Yu X; Hatakeyama M
    Mol Cell Biochem; 2006 Apr; 285(1-2):165-71. PubMed ID: 16477370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.
    Egeblad M; Jäättelä M
    Int J Cancer; 2000 Jun; 86(5):617-25. PubMed ID: 10797281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB-4 activation promotes neurite outgrowth in PC12 cells.
    Vaskovsky A; Lupowitz Z; Erlich S; Pinkas-Kramarski R
    J Neurochem; 2000 Mar; 74(3):979-87. PubMed ID: 10693928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.
    Junttila TT; Sundvall M; Määttä JA; Elenius K
    Trends Cardiovasc Med; 2000 Oct; 10(7):304-10. PubMed ID: 11343971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4.
    Zhang D; Sliwkowski MX; Mark M; Frantz G; Akita R; Sun Y; Hillan K; Crowley C; Brush J; Godowski PJ
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9562-7. PubMed ID: 9275162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.